Adello Biologics, LLC
20 New England Avenue
Adello Biologics is a fully integrated biosimilar developer headquartered in New Jersey, one of the major biotech hubs in the United States. At Adello, we lead with science to accelerate development and drive manufacturing efficiency with the goal of providing high-quality, affordable biosimilars to patients worldwide.
CEO: Peter F. Moesta
CSO: Mike Washabaugh
Please click here for Adello job opportunities.
Please click here for clinical trial information.